Uzbekistan's pharma market is growing, imports predominate
This article was originally published in Scrip
Executive Summary
Pharmaceutical sales in Uzbekistan grew by 11% last year to $285 million, reports RMBC, the Moscow-based market research company (now part of IMS Health).